Background: TransCarotid artery revascularization (TCAR) is a safe minimally invasive option for patients with carotid artery stenosis who are not appropriate candidates for carotid endarterectomy (CEA). Many physicians have not yet adopted this technique in the management of carotid artery stenosis. The aim of this study is to explore overall outcomes of carotid revascularization based on physicians' practices in the Vascular Quality Initiative (VQI).

Methods: Individual physicians participating in both the carotid artery stenting (CAS) and carotid endarterectomy (CEA) modules in VQI were categorized as performing CEA and TCAR, CEA and transfemoral carotid artery stenting (TfCAS) or all 3 procedures (CEA, TCAR and TFCAS). Physicians performing CEA only or TCAR/TfCAS only were excluded. In-hospital and one-year outcomes were compared between the 3 groups using univariable and multivariable analysis.

Results: A total of 104,925 carotid revascularization procedures performed by 1,433 physicians were included. Most physicians performed CEA and TCAR (n=714, 49.8%), while 35.1% (n=503) performed all 3 procedures and 15.1% (n=216) performed CEA and TfCAS only. Physicians performing CEA and TfCAS had higher overall stroke/death rates after carotid procedures (2.2%) compared to those performing CEA and TCAR (1.4%) or those performing all 3 procedures (1.6%, p<.001). They also had higher rates of cranial nerve injuries (3.1% vs. 1.9% vs. 1.9%, p<.001). After adjusting for baseline characteristics, procedures performed by CEA and TfCAS physicians had significantly higher odds of in-hospital stroke/death compared with those in the CEA and TCAR group (OR 1.31, 95%CI 1.03-1.66, p=.03]. They also had increased hazard of 1-year stroke/death (HR 1.45, 95% CI 1.1-1.9, p=.01). No significant difference in the adjusted odds of stroke/death was observed between CEA and TCAR performers versus (CEA, TCAR and TfCAS) performers [OR 1.05; 95% CI 0.92-1.20, p=.44]. When adjusting for the type of carotid revascularization technique, difference in outcomes based on surgeon's experience were no longer significant, indicating that differences in outcomes were procedure-specific and attributable to the inferior outcomes associated with TfCAS compared to CEA and TCAR. TCAR case volumes did not impact outcomes of carotid revascularization. On the other hand, a high TfCAS volume among physicians performing all 3 carotid procedures was associated with higher overall in-hospital and one-year mortality.

Conclusions: Physicians' preference for carotid artery stenosis management has a bearing on their overall stroke/death rates. Careful patient and procedure selection are the cornerstone to improve carotid revascularization outcomes.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jvs.2024.12.125DOI Listing

Publication Analysis

Top Keywords

carotid artery
16
performing cea
16
cea tcar
16
carotid revascularization
12
carotid
10
cea
10
artery stenosis
8
carotid endarterectomy
8
endarterectomy cea
8
artery stenting
8

Similar Publications

It remains unclear why unilateral proximal carotid artery occlusion (UCAO) causes benign oligemia in mice, yet leads to various outcomes (asymptomatic-to-death) in humans. We hypothesized that inhibition of nitric oxide synthase (NOS) both transforms UCAO-mediated oligemia into full infarction and expands pre-existing infarction. Using 900 mice, we i) investigated stroke-related effects of UCAO with/without intraperitoneal administration of the NOS inhibitor (NOSi) N-nitro-L-arginine methyl ester (L-NAME, 400 mg/kg); ii) examined the rescue effect of the NO-donor, molsidomine (200 mg/kg at 30 minutes); and iii) tested the impact of antiplatelet medications.

View Article and Find Full Text PDF

Postinterventional restenosis is a major challenge in the treatment of peripheral vascular disease. Current anti-restenosis drugs inhibit neointima hyperplasia but simultaneously impair endothelial repair due to indiscrminative cytotoxity. Stem cell-derived exosomes provide multifaceted therapeutic effects by delivering functional miRNAs to endothelial cells, macrophages, and vascular smooth muscle cells (VSMCs).

View Article and Find Full Text PDF

Intimal hyperplasia (IH) remains a significant clinical problem, causing vascular intervention failure. This study aimed to elucidate whether gangliosides GA2 accumulated in atherosclerotic mouse aortae and plasma promote the development of IH. We identified that GA2 was remarkably accumulated in both artery and plasma of atherosclerotic patients and mice.

View Article and Find Full Text PDF

Background: Given the lack of models for carotid artery dissections (CAD), we aim to investigate effects of beta-aminopropionitrile (BAPN) combined with physical damage on the arterial walls of rats, and to establish a high-incidence and low-mortality CAD model.

Methods: Sixteen SPF SD rats (3-week-old) were divided into two groups. Group B was given 0.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!